Display options
Cite
Rajavi Z, Safi S, Javadi MA, et al. Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure. J Ophthalmic Vis Res. 2017;12(1):65-80doi: 10.4103/jovr.jovr_253_16.
Rajavi, Z., Safi, S., Javadi, M. A., Jafarinasab, M. R., Feizi, S., Moghadam, M. S., Jadidi, K., Babaei, M., Shirvani, A., Baradaran-Rafii, A., Mohammad-Rabei, H., Ziaei, H., Ghassemi-Broumand, M., Baher, S. D., Naderi, M., Panahi-Bazaz, M., Zarei-Ghanavati, S., Hanjani, S., Ghasemi, H., Salouti, R., Pakbin, M., & Kheiri, B. (2017). Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure. Journal of ophthalmic & vision research, 12(1), 65-80. https://doi.org/10.4103/jovr.jovr_253_16
Rajavi, Zhale, et al. "Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure." Journal of ophthalmic & vision research vol. 12,1 (2017): 65-80. doi: https://doi.org/10.4103/jovr.jovr_253_16
Rajavi Z, Safi S, Javadi MA, Jafarinasab MR, Feizi S, Moghadam MS, Jadidi K, Babaei M, Shirvani A, Baradaran-Rafii A, Mohammad-Rabei H, Ziaei H, Ghassemi-Broumand M, Baher SD, Naderi M, Panahi-Bazaz M, Zarei-Ghanavati S, Hanjani S, Ghasemi H, Salouti R, Pakbin M, Kheiri B. Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure. J Ophthalmic Vis Res. 2017 Jan-Mar;12(1):65-80. doi: 10.4103/jovr.jovr_253_16. PMID: 28299009; PMCID: PMC5340066.
Copy Download .nbib Format: NLM
Share it on

J Ophthalmic Vis Res. 2017 Jan-Mar;12(1):65-80. doi: 10.4103/jovr.jovr_253_16.

Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure.

Journal of ophthalmic & vision research

Zhale Rajavi, Sare Safi, Mohammad Ali Javadi, Mohammad Reza Jafarinasab, Sepehr Feizi, Mohammadreza Sedighi Moghadam, Khosrow Jadidi, Mahmoud Babaei, Armin Shirvani, Alireza Baradaran-Rafii, Hossein Mohammad-Rabei, Hossein Ziaei, Mohammad Ghassemi-Broumand, Siamak Delfaza Baher, Mostafa Naderi, Mahmoodreza Panahi-Bazaz, Siamak Zarei-Ghanavati, Shahriar Hanjani, Hassan Ghasemi, Ramin Salouti, Mojgan Pakbin, Bahareh Kheiri

Affiliations

  1. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  3. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  4. Janbazan Medical and Engineering Research Center, Tehran, Iran.
  5. Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  6. Standardization and CPG Development Office, Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran.
  7. Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  8. Department of Ophthalmology, Torfeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  9. Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  10. Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  11. Department of Ophthalmology, Mashhad University of Medical Sciences, Mashhad, Iran.
  12. Department Research and Development, Parsian Clinic of Ophthalmology, Isfahan, Iran.
  13. Department of Ophthalmology, Shahed University, Tehran, Iran.
  14. Department of Ophthalmology, Shiraz University of Medical Sciences, Tehran, Iran.

PMID: 28299009 PMCID: PMC5340066 DOI: 10.4103/jovr.jovr_253_16

Abstract

PURPOSE: To develop clinical practice guidelines (CPGs) for prevention, diagnosis, treatment and follow-up of ocular injuries caused by exposure to mustard gas.

METHODS: The clinical questions were designed by the guideline team. Websites and databases including National Guidelines Clearinghouse, National Institute for Clinical Excellence, Cochrane, and PubMed were searched to find related CPGs and explore possible answers to the clinical questions. Since there were no relevant CPGs in the literature, related articles in Persian and English languages were extracted. Each article along with its level of evidence was summarized. Additionally, hand search was performed by looking the reference list of each article. Consequently, recommendations were developed considering the clinical benefits and side effects of each therapeutic modality. The recommendations were re-evaluated in terms of customization criteria. All recommendations along with the related evidence were scored from 1 to 9 by experts from all medical universities of Iran. The level of agreement among the experts was evaluated by analyzing the given scores.

RESULTS: The agreement was achieved for all recommendations. The experts suggested a number of minor modifications which were applied to the recommendations. Finally, CPGs were developed with 98 recommendations under three major domains including prevention of injury, diagnosis and management of the acute and delayed-onset mustard gas ocular injuries.

CONCLUSION: Considering the lack of CPGs for the prevention, diagnosis, and management of mustard gas-induced keratitis, these recommendations would be useful to prevent the serious ocular complications of mustard gas and standardize eye care services to the affected individuals.

Keywords: Clinical Practice Guidelines; Eye Injury; Iran; Mustard Gas

Conflict of interest statement

There are no conflicts of interest.

References

  1. Fundam Clin Pharmacol. 2005 Jun;19(3):297-315 - PubMed
  2. J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):417-22 - PubMed
  3. Clin Exp Ophthalmol. 2006 May-Jun;34(4):342-6 - PubMed
  4. Ophthalmology. 2010 Feb;117(2):246-52 - PubMed
  5. Ann Plast Surg. 1987 Oct;19(4):330-3 - PubMed
  6. Cutan Ocul Toxicol. 2009;28(2):71-7 - PubMed
  7. Am J Ophthalmol. 2014 Dec;158(6):1305-1309.e4 - PubMed
  8. Ocul Surf. 2011 Jul;9(3):163-78 - PubMed
  9. Harefuah. 2014 Mar-Apr;153(3-4):199-205, 237 - PubMed
  10. Surv Ophthalmol. 1997 May-Jun;41(6):461-6 - PubMed
  11. Chem Biol Interact. 2013 Dec 5;206(3):491-5 - PubMed
  12. Emerg Health Threats J. 2008;1:e7 - PubMed
  13. Int Immunopharmacol. 2009 Dec;9(13-14):1499-503 - PubMed
  14. Toxicology. 2005 Oct 30;214(3):198-209 - PubMed
  15. Cornea. 2013 Apr;32(4):396-400 - PubMed
  16. Br J Ophthalmol. 1943 Feb;27(2):54-60 - PubMed
  17. J Med Toxicol. 2009 Dec;5(4):191-5 - PubMed
  18. Br J Ophthalmol. 1944 Sep;28(9):441-7 - PubMed
  19. Int Immunopharmacol. 2013 Nov;17(3):980-5 - PubMed
  20. Toxicology. 2009 Sep 1;263(1):9-11 - PubMed
  21. Cutan Ocul Toxicol. 2013 Oct;32(4):304-24 - PubMed
  22. Chem Biol Interact. 2013 Dec 5;206(3):512-22 - PubMed
  23. Invest Ophthalmol Vis Sci. 2013 Oct 15;54(10):6735-44 - PubMed
  24. J Nerv Ment Dis. 2008 Oct;196(10):772-5 - PubMed
  25. Cornea. 2013 Apr;32(4):e44-50 - PubMed
  26. Bull N Y Acad Med. 1943 May;19(5):356-67 - PubMed
  27. Basic Clin Pharmacol Toxicol. 2006 Oct;99(4):273-82 - PubMed
  28. Am J Ophthalmol. 2011 Dec;152(6):925-932.e2 - PubMed
  29. Daru. 2012 Oct 09;20(1):51 - PubMed
  30. Int Ophthalmol Clin. 1971 Fall;11(3):1-13 - PubMed
  31. Int Immunopharmacol. 2009 Dec;9(13-14):1494-8 - PubMed
  32. Cutan Ocul Toxicol. 2012 Mar;31(1):48-52 - PubMed
  33. Cornea. 2011 Jun;30(6):620-3 - PubMed
  34. Cutan Ocul Toxicol. 2008;27(4):317-26 - PubMed
  35. Am J Ophthalmol. 1999 Oct;128(4):506-7 - PubMed
  36. Cornea. 2007 Oct;26(9):1074-8 - PubMed
  37. Cornea. 2009 Jan;28(1):51-7 - PubMed
  38. Ophthalmology. 2005 Apr;112(4):617-25 - PubMed
  39. Int Ophthalmol Clin. 1989 Fall;29(3):153-8 - PubMed
  40. Invest Ophthalmol. 1976 Jun;15(6):486-9 - PubMed
  41. Acta Ophthalmol Suppl. 1985;173:30-1 - PubMed
  42. Toxicology. 2009 Sep 1;263(1):59-69 - PubMed
  43. Asian Pac J Cancer Prev. 2015;16(17):7567-73 - PubMed
  44. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2966-72 - PubMed
  45. Clin Exp Dermatol. 2006 Jan;31(1):1-5 - PubMed
  46. Trans Am Ophthalmol Soc. 1947;45:81-92 - PubMed
  47. Cornea. 2012 Mar;31(3):280-90 - PubMed
  48. Int Immunopharmacol. 2009 Dec;9(13-14):1466-70 - PubMed
  49. Cornea. 2010 Aug;29(8):889-94 - PubMed
  50. Environ Health Perspect. 1992 Nov;98 :259-80 - PubMed
  51. Ophthalmology. 2011 Jul;118(7):1272-81 - PubMed
  52. Mil Med. 2001 Jan;166(1):67-70 - PubMed
  53. Skinmed. 2003 Jul-Aug;2(4):215-21 - PubMed
  54. Dermatol Clin. 1999 Jan;17(1):41-60, viii - PubMed
  55. Cornea. 2009 May;28(4):458-62 - PubMed

Publication Types